Back to search

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

Data up to Jan 2025

Published1985
Citations355
References22

Total Citations Per Year

Abstract

References (22)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1965 • 3,333 citations

Metastases from transitional cell carcinoma of urinary bladder

1980 • 226 citations

Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.

1976 • 142 citations

A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a study

1983 • 100 citations

Methotrexate: An active drug in bladder cancer

1981 • 96 citations

Combination Chemotherapy (CISCA) for Advanced Urinary Tract Carcinoma

1977 • 92 citations

Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer

1981 • 81 citations

Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.

1979 • 69 citations

Cis-Diamminedichloride Platinum II in the Treatment of Abvanced Bladder Cancer

1980 • 66 citations

Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors

1982 • 66 citations

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California oncology group study

1983 • 66 citations

Effect of chemotherapeutic agents on bladder cancer: a new animal model.

1973 • 49 citations

Single and combination chemotherapy for primary murine bladder cancer

1975 • 48 citations

Phase II Trial of Sequentially Administered Cisplatin, Cyclophosphamide and Doxorubicin for Urothelial Tract Tumors

1983 • 46 citations

The Management of Advanced Bladder Carcinoma

1981 • 33 citations

A Phase 2 Study of Cis‐platinum in Patients with Recurrent Bladder Carcinoma

1981 • 31 citations

cis-Platinum combination chemotherapy of bladder cancer: an update.

1979 • 29 citations

Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group.

1981 • 27 citations

Chemotherapy for metastatic transitional carcinoma of the urinary tract:A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure

1983 • 24 citations

Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study

1982 • 23 citations

A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract

1983 • 16 citations

Cited By (0)

Loading...
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for… (1985) – Journal of Clinical Oncology | Metascience Observatory Explorer